CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Revenue

CNBX Pharmaceuticals had revenue of $230.07K in the twelve months ending May 31, 2024, down -32.36% year-over-year. In the fiscal year ending August 31, 2023, CNBX Pharmaceuticals had annual revenue of $410.17K with 1,269.13% growth.

• Revenue (ttm): $230.07K
• Revenue Growth: -32.36%
• P/S Ratio: 0.35
• Revenue / Employee: $270,120
• Employees: 2
• Market Cap: 311.11K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2023	410.17K	380.21K	1,269.13%
Aug 31, 2022	29.96K	-	-
Aug 31, 2021	-	-	-
Aug 31, 2020	7.16K	-2.69K	-27.29%
Aug 31, 2019	9.84K	242.00	2.52%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.